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Table 1
Spatial Regression Results
6.6 (p <0.01; chlamydia), 6.7 (p <0.01; gonorrhea) and 4.0 (p <0.01;
P&S syphilis) times more likely to be hot spots (Table 1).
Conclusion: Our study provides important information on hot
spot clusters of non-viral STIs in the entire US, including associa-
tions between hot spot counties and socio-economic/demographic
factors.
http://dx.doi.org/10.1016/j.ijid.2016.02.139
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Background: Vibrio cholerae accessory cholera enterotoxin
(ACE) is the third toxin alone with cholera toxin and zonula
occludens toxin that cause secretary diarrhea by activating Ca2+-
dependent Cl-/HCO3- symporters. However, the identity of the
underlying signalosomes and Cl- channel speciﬁcally activated by
ACE is unknown because of the low amount of toxin produced by
V. cholerae.
Methods&Materials: Using previously established biologically
active recombinant ACE, Ussing chamber and patch clamp tech-
niques, we examine the identity of unknown apical Cl- channel
activated by ACE to cause diarrhea.
Results: We observed ACE induce apical Cl conductance (ICl-)
sensitive to classical calcium activated Cl channel (CaCC) block-
ers such as NPPB, niﬂumic acid, and AO1 but was neither affected
by ANO1 (TMEM16A) speciﬁc inhibitor T16A-AO1 nor by CFTR
blocker, CFTRinh-172. In vivo mice ileal loop experiment reveal
similar sensitivity of ACE induced ﬂuid accumulation in presence
of various CaCC inhibitors. Based on these pharmacological studies,
we hypothesized ACE activated CaCC ANO6 (TMEM16F) to induce
apical Cl- secretion. This hypothesis validated by robust ANO6
expression in intestinal epithelial cell model Caco2 cell line and
reduced ICl in ANO6 knockdown Caco2 cell relative to wild type
Caco2 cells. The role of ANO6 in ACE induced Cl- secretion was
further conﬁrmed by measuring whole cell patch clamp record-
ings of Cl- currents upon ACE exposure in HEK293 cells transiently
expressing ANO6-GFP but not ANO1-mCherry. However, treat-
ment with calcium ionophore A23187 induced strong outwardly
rectifying ANO1 and ANO6 currents in these HEK 293 cells. Sur-
prisingly, ACE was not able to induce [Ca2+]i rise in these cells.
Together, these data indicate ACE elicits whole cell Cl- currents
by calcium-independent mechanism of ANO6 activation by ACE.
Further investigation reveal Caco2 cells expose to ACE cause signif-
icant RhoA translocation to plasmamembranewhile ACE evoke ICl-
decreases in presence of RhoA kinase (ROCK) inhibitor, H1152 and
PI4K inhibitor, wortmannin and PAO which reduces plasma mem-
brane PIP2 level. We have also identify PIP2 binding motif at the
N-terminal sequence among human and mouse ANO6 variants.
Conclusion: We conclude increased plasma membrane PIP2
level via RhoA-ROCK-PIP2 signaling cascade induced speciﬁc acti-
vation of ANO6 by during ACE mediated secretary diarrhea.
http://dx.doi.org/10.1016/j.ijid.2016.02.140
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Background: Antimicrobial Management Teams (AMT) play
an integral role in modifying antimicrobial utilization (AU). In
2004, AMT at Shands UF developed restricted antimicrobial
policy (RAP) with institutional criteria for carbapenems (CAR),
piperacillin/tazobactam (P/T), daptomycin (DAP), echinocandins
(EC), cefepime (CEF) and ﬂuoroquinolones (FQ). In 2008, AMT was
disassembled due to pharmacist attrition but RAP remained under
Infectious Diseases (ID). AMTwas re-initiated in 2010 and later fur-
ther expanded.We report the experience of the AMTover a 10-year
period and the impact on consumption, resistance, drug costs and
various oppurtunities, challenges and strategies.
Methods & Materials: A retrospective evaluation was per-
formed to compare the consumption of targeted antimicrobials,
measured as deﬁned daily dose per 1000 patient days, before and
after AUmanagement strategieswere initiated and alsowhen AMT
was disassembled and again when it was re-initiated. AU, Acquisi-
tion costs (AC) and Resistance rates (RR) from2003were compared
to 2006/7 and also from 2008 was compared to 2010. Following re-
implementation, AMT’s central role focusedonRAPadherencewith
direct prescriber feedback on Days 3 and 7 of therapy.
Results: With Initiation of AMT in 2004, consumption of most
anti-pseudomonal antibiotics fell: IMI (-80%), P/T (-22%), T/C (-60%),
CEF (-3.8%) and FQs (-37%). Resistance among Pseudmonas to tar-
geted antibiotics has stabilized and displays a downward trend.
Antimicrobial drug acquisition costs decreased by 18%.
Following loss of AMT, antimicrobial expenditure (AE) and
antibiotic cost per patient day (ACPD) increased by 33 and 22%
respectively. Increased consumption of aztreonam (78%), CEF (6%),
